|
Volumn 108, Issue 1, 2008, Pages 90-94
|
Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)
|
Author keywords
Carboplatin; Ovarian cancer; Pegylated liposomal doxorubicin; Platinum sensitive
|
Indexed keywords
CARBOPLATIN;
DOCETAXEL;
DOXORUBICIN;
PACLITAXEL;
PLATINUM DERIVATIVE;
ABDOMINAL PAIN;
ADULT;
AGED;
ANEMIA;
AREA UNDER THE CURVE;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DYSPNEA;
FATIGUE;
FEBRILE NEUTROPENIA;
FISHER EXACT TEST;
GRANULOCYTOPENIA;
HUMAN;
HYPOMAGNESEMIA;
HYPONATREMIA;
HYPOTENSION;
INFECTION;
INTESTINE OBSTRUCTION;
LETHARGY;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALAISE;
MONOTHERAPY;
MYALGIA;
NAUSEA;
NEUTROPENIA;
OVARY CARCINOMA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT INFECTION;
THROMBOCYTOPENIA;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VOMITING;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PERITONEAL NEOPLASMS;
POLYETHYLENE GLYCOLS;
|
EID: 37349126263
PISSN: 00908258
EISSN: 10956859
Source Type: Journal
DOI: 10.1016/j.ygyno.2007.08.075 Document Type: Article |
Times cited : (115)
|
References (8)
|